by Raymond Tel | Sep 15, 2017 | News
In the range of compounds for protecting organs from Sulfateq a new paper is published. We are proud to announce that Dr. L.E. (Leo) Deelman (UMCG) has published his paper on the protective effects of our SUL-121 compound in diabetes. SUL-121 preserves endothelial...
by Raymond Tel | Sep 11, 2017 | News
Tonight (11 September 2017) please tune in to BBC2. At 22:00 (Dutch time), Professor Rob Henning of the UMCG discusses the need for human hibernation. In this episode of “The search for a new world” Christophe meets anaesthesiologist Dr. Rob Henning, who...
by Raymond Tel | Mar 27, 2017 | News
Sulfateq B.V. is dedicated to developing new drugs for several diseases: Acute Kidney Injury (AKI), Chronic Obstructive Pulmonary Disease (COPD), Type II Diabetes (T2D) and obesity. We can now proudly announce that the SUL-compounds are being tested in sepsis, which...
by Raymond Tel | Jan 17, 2017 | Uncategorized
Lately there is a lot of happening at Sulfateq which is very positive for the development of ROKEPIE. Besides our new website there are also multiple publications and papers which have been published or will be published in the near future. What’s even greater is that...
by Raymond Tel | Nov 1, 2016 | Events, News
From 7 till 9 November 2016 we will be attending BIO-Europe 2016 in Cologne (Germany). BIO-Europe is Europe’s largest partnering conference serving the global biotechnology industry. Our CEO Kees van der Graaf will be present on these days to talk about business...
